Bionano Genomics Inc. (NASDAQ:BNGO) went up by 5.85% from its latest closing price compared to the recent 1-year high of $15.69. The company’s stock price has collected 15.98% of gains in the last five trading sessions. Press Release reported on 02/11/21 that Bionano Genomics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Is It Worth Investing in Bionano Genomics Inc. (NASDAQ :BNGO) Right Now?
Opinions of the stock are interesting as 3 analysts out of 4 who provided ratings for Bionano Genomics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $10.94, which is -$2.63 below the current price. BNGO currently public float of 151.94M and currently shorts hold a 17.57% ratio of that float. Today, the average trading volume of BNGO was 85.78M shares.
BNGO’s Market Performance
BNGO stocks went up by 15.98% for the week, with a monthly jump of 68.57% and a quarterly performance of 2441.67%, while its annual performance rate touched 1168.22%. The volatility ratio for the week stands at 13.47% while the volatility levels for the past 30 days are set at 12.97% for Bionano Genomics Inc.. The simple moving average for the period of the last 20 days is 15.24% for BNGO stocks with a simple moving average of 560.48% for the last 200 days.
Analysts’ Opinion of BNGO
Many brokerage firms have already submitted their reports for BNGO stocks, with Ladenburg Thalmann repeating the rating for BNGO by listing it as a “Buy.” The predicted price for BNGO in the upcoming period, according to Ladenburg Thalmann is $1.25 based on the research report published on September 24th of the previous year 2020.
Oppenheimer, on the other hand, stated in their research note that they expect to see BNGO reach a price target of $1.50. The rating they have provided for BNGO stocks is “Outperform” according to the report published on April 08th, 2020.
BNGO Trading at 107.83% from the 50-Day Moving Average
After a stumble in the market that brought BNGO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.51% of loss for the given period.
Volatility was left at 12.97%, however, over the last 30 days, the volatility rate increased by 13.47%, as shares surge +64.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2,466.19% upper at present.
During the last 5 trading sessions, BNGO rose by +15.98%, which changed the moving average for the period of 200-days by +3,471.05% in comparison to the 20-day moving average, which settled at $12.04. In addition, Bionano Genomics Inc. saw 340.58% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for BNGO
Current profitability levels for the company are sitting at:
- -255.44 for the present operating margin
- +22.46 for the gross margin
The net margin for Bionano Genomics Inc. stands at -294.34. The total capital return value is set at -120.73, while invested capital returns managed to touch -261.76. Equity return is now at value -748.80, with -126.50 for asset returns.
Based on Bionano Genomics Inc. (BNGO), the company’s capital structure generated 555.80 points at debt to equity in total, while total debt to capital is 84.75.
When we switch over and look at the enterprise to sales, we see a ratio of 2.11, with the company’s debt to enterprise value settled at 0.94. The receivables turnover for the company is 1.87 and the total asset turnover is 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.07.